Source: Click2Houston

video
z

HOUSTON – The Food and Drug Administration has revoked its emergency use authorization for hydroxychloroquine as a treatment for the coronavirus.

At Houston’s United Memorial Medical Center, dozens of COVID-19 patients have taken the drug, according to Dr. Joseph Varon, chief medical officer.

“Hydroxychloroquine works,” Dr. Varon said. “I know a number of people think that it doesn’t but we have treated more than 100 patients in the hospital with hydroxychloroquine and the patients have done well.”

Dr. Varon believes the treatment is effective, as long as it’s given early to patients and they’re closely monitored in the hospital.

“It usually takes about three to four days before you can start seeing an improvement in patients. By day four or day five, they really do better,” said Dr. Varon.

He plans to continue using the drug until he finds a better alternative.

Related:

Association of American Physicians & Surgeons (AAPS) Sues the FDA to End Its Arbitrary Restrictions on Hydroxychloroquine

Documentary: Perspectives on the Pandemic | The (Undercover) Epicenter Nurse | Episode Nine

FDA enables use of HCQ in a weird round about way – by revoking EUA. Says they never restricted it.

Share on facebook
Share on twitter
Share on whatsapp
On Trend

Latest Stories

Stark madness to ban ivermectin

Buried in the note is the real reason for making ivermectin inaccessible – the fear that persons taking it ‘may elect not to be vaccinated as part of the national Covid-19 vaccination program’. This is outrageous. When someone is infected with Covid, it is too late to bother with vaccination. They need early treatment. To deny it to coerce them into accepting a vaccine, one of whose side-effects is death, is immoral.

Read More »

Australia’s TGA Bans GPs from Prescribing Ivermectin

Australia’s medicine and therapeutic regulatory, the Therapeutic Good Administration (TGA) recently took the gloves off with Ivermectin, the economical anti-parasitic drug associated with at least 63 completed clinical trials involving SARS-CoV-2, the virus behind COVID-19. Now TGA formally places a national prohibition on off-label prescribing of ivermectin to all general practitioners. A comparable move as to what TGA did with hydroxychloroquine in 2020. Clearly further evidence of tightening encroachment of the critically important doctor-patient treatment relationship allowing consent to medical treatment using off-label medications. Of course, this isn’t occurring in a vacuum—it’s part of an unfolding, integrated and what have the signs of a coordinated and orchestrated government action to stop any and all treatments other than those the government declares acceptable.

Read More »